When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Eli Lilly's Popular Weight Loss/Diabetes Drug ... - AOL

   www.aol.com/eli-lillys-popular-weight-loss...

   HFpEF accounts for nearly half of all heart failure cases, and in the U.S., almost 60% of those impacted also live with obesity. HFpEF is a condition in which the heart’s left pumping chamber ...

3. Lilly says weight loss drug cuts heart failure risk by ... - AOL

   www.aol.com/news/lilly-says-weight-loss-drug...

   (Reuters) -Trial results show Eli Lilly's weight loss drug Zepbound reduces the risk of hospitalization, death and other outcomes for obese adults with a common type of heart failure, the company ...

4. Weight loss drug Zepbound may reduce death risk from heart ...

   www.aol.com/weight-loss-drug-zepbound-may...

   To accurately determine whether it is the drug itself, and not just weight loss, that is the beneficial factor cannot be known until the drug is utilized as a treatment for heart failure in non ...

5. Management of heart failure - Wikipedia

   en.wikipedia.org/wiki/Management_of_heart_failure

   Sleep apnea is an under-recognized risk factor for heart failure. Uncontrolled sleep apnea may increase the risk of heart failure by up to 140%. [4] Weight reduction – through physical activity and dietary modification, as obesity is a risk factor for heart failure and left ventricular hypertrophy. Effective weight management has been shown ...

6. Heart failure - Wikipedia

   en.wikipedia.org/wiki/Heart_failure

   Nearly one of every four people (24.7%) hospitalized in the U.S. with congestive heart failure is readmitted within 30 days. [144] Additionally, more than 50% of people seek readmission within 6 months after treatment and the average duration of hospital stay is 6 days. Heart failure is a leading cause of hospital readmissions in the U.S.

7. Popular weight loss drug found to reduce risk of heart ... - AOL

   www.aol.com/popular-weight-loss-drug-found...

   Taking a weight loss drug may also help reduce the risk of heart attack, stroke and cardiac death, data shows. Wegovy, a drug approved by the U.S. Food and Drug Administration to treat obesity ...